SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Beate Hauglann, Jūratė Šaltytė Benth, Sophie D. Fosså, Alv A. Dahl, A cohort study of permanently reduced work ability in breast cancer patients, Journal of Cancer Survivorship, 2012,

    CrossRef

  2. 2
    Yin Ting Cheung, Earl Hsien-Jie Tan, Alexandre Chan, An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors, Supportive Care in Cancer, 2012, 20, 7, 1361

    CrossRef

  3. 3
    Ellyn E. Matthews, Sarah J. Schmiege, Paul F. Cook, Karen H. Sousa, Breast Cancer and Symptom Clusters During Radiotherapy, Cancer Nursing, 2012, 35, 2, E1

    CrossRef

  4. 4
    Da-Zhi Liu, Bradley P. Ander, Cell Cycle Inhibition without Disruption of Neurogenesis Is a Strategy for Treatment of Aberrant Cell Cycle Diseases: An Update, The Scientific World Journal, 2012, 2012, 1

    CrossRef

  5. 5
    Jeffrey S. Wefel, Sanne B. Schagen, Chemotherapy-Related Cognitive Dysfunction, Current Neurology and Neuroscience Reports, 2012, 12, 3, 267

    CrossRef

  6. 6
    Christopher M. Nguyen, Torricia H. Yamada, Leigh J. Beglinger, Joseph E. Cavanaugh, Natalie L. Denburg, Susan K. Schultz, Cognitive features 10 or more years after successful breast cancer survival: comparisons across types of cancer interventions, Psycho-Oncology, 2012, 21,
  7. 7
    Kristin M. Phillips, Heather S. Jim, Brent J. Small, Christine Laronga, Michael A. Andrykowski, Paul B. Jacobsen, Cognitive functioning after cancer treatment, Cancer, 2012, 118, 7
  8. 8
    Michelle Monje, Jörg Dietrich, Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis, Behavioural Brain Research, 2012, 227, 2, 376

    CrossRef

  9. 9
    Bok Yae Chung, Hye Sun Byun, Gyung Duck Kim, Kyung Hae Kim, Eun Hee Choi, Experiences of Changes in Cognitive Function for Women treated with Chemotherapy for Breast Cancer, Korean Journal of Women Health Nursing, 2012, 18, 1, 1

    CrossRef

  10. 10
    N. BIGLIA, V.E. BOUNOUS, A. MALABAILA, D. PALMISANO, D.M.E. TORTA, M. D'ALONZO, P. SISMONDI, R. TORTA, Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study, European Journal of Cancer Care, 2012, 21, 3
  11. 11
    Travis T Wager, Jennifer L Liras, Scot Mente, Patrick Trapa, Strategies to minimize CNS toxicity:in vitrohigh-throughput assays and computational modeling, Expert Opinion on Drug Metabolism & Toxicology, 2012, 8, 5, 531

    CrossRef

  12. 12
    B. Collins, Acute and Late Onset Cognitive Dysfunction Associated With Chemotherapy in Women With Breast Cancer, Breast Diseases: A Year Book Quarterly, 2011, 22, 2, 208

    CrossRef

  13. 13
    Michelle C. Janelsins, Sadhna Kohli, Supriya G. Mohile, Kenneth Usuki, Tim A. Ahles, Gary R. Morrow, An Update on Cancer- and Chemotherapy-Related Cognitive Dysfunction: Current Status, Seminars in Oncology, 2011, 38, 3, 431

    CrossRef

  14. 14
    Brent J. Small, Kerri Sharp Rawson, Erin Walsh, Heather S. L. Jim, Tiffany F. Hughes, Lindsay Iser, Michael A. Andrykowski, Paul B. Jacobsen, Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors, Cancer, 2011, 117, 7
  15. 15
    J E Fardell, J Vardy, I N Johnston, G Winocur, Chemotherapy and Cognitive Impairment: Treatment Options, Clinical Pharmacology & Therapeutics, 2011, 90, 3, 366

    CrossRef

  16. 16
    David M. Peereboom, Clinical Trial Design in Brain Metastasis: Approaches for a Unique Patient Population, Current Oncology Reports, 2011, 14, 1, 91

    CrossRef

  17. 17
    Florence Joly, Olivier Rigal, Sabine Noal, Bénédicte Giffard, Cognitive dysfunction and cancer: which consequences in terms of disease management?, Psycho-Oncology, 2011, 20, 12
  18. 18
    Michelle C. Janelsins, Karen M. Mustian, Oxana G. Palesh, Supriya G. Mohile, Luke J. Peppone, Lisa K. Sprod, Charles E. Heckler, Joseph A. Roscoe, Alan W. Katz, Jacqueline P. Williams, Gary R. Morrow, Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research, Supportive Care in Cancer, 2011, 20, 4, 831

    CrossRef

  19. 19
    M. Lange, B. Giffard, F. Eustache, N. Morel, S. Noal, F. Joly, Impact de la chimiothérapie adjuvante sur les fonctions cognitives dans le cancer du sein: revue de la littérature, Psycho-Oncologie, 2011, 5, 1, 3

    CrossRef

  20. 20
    Jeffrey S Wefel, Janette Vardy, Tim Ahles, Sanne B Schagen, International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer, The Lancet Oncology, 2011, 12, 7, 703

    CrossRef

  21. 21
    S. Loibl, A. Lintermans, A.S. Dieudonné, P. Neven, Management of menopausal symptoms in breast cancer patients, Maturitas, 2011, 68, 2, 148

    CrossRef

  22. 22
    Yin Ting Cheung, Wai Keung Chui, Alexandre Chan, Neuro-cognitive impairment in breast cancer patients: Pharmacological considerations, Critical Reviews in Oncology/Hematology, 2011,

    CrossRef

  23. 23
    Jeffrey M. Long, Garrick D. Lee, Bennett Kelley-Bell, Edward L. Spangler, Evelyn J. Perez, Dan L. Longo, Rafael de Cabo, Sige Zou, Peter R. Rapp, Preserved learning and memory following 5-fluorouracil and cyclophosphamide treatment in rats, Pharmacology Biochemistry and Behavior, 2011, 100, 1, 205

    CrossRef

  24. 24
    Tim Ahles, Sanne Schagen, Janette Vardy, Neurocognitive Effects of Anticancer Treatments,